MedTrace Logo

Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)

NCT00807534 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2011-02-09

No results posted yet for this study

Summary

This study was designed to test the following hypothesis:

The 3-min constant rate step test and the 3-min constant rate shuttle walk test will be sensitive to detect improvement in exertional dyspnea following acute bronchodilation in patients with COPD.

Conditions

Interventions

DRUG

ipratropium bromide

ipratropium bromide nebulization

DRUG

placebo

placebo nebulization

BEHAVIORAL

constant rate step test

nebulization of 500ug

BEHAVIORAL

constant rate shuttle walk test

nebulization of 500ug

Sponsors & Collaborators

Principal Investigators

  • François Maltais, MD · Laval University

  • Hélène Perrault, Ph.D. · McGill University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-12-31
Completion
2010-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00807534 on ClinicalTrials.gov